Health care stocks continued to lose ground Tuesday afternoon, with the NYSE Health Care Index sinking 1.2% and the SPDR Health Care Select Sector ETF...
Health care stocks still were mostly lower this afternoon, with the NYSE Health Care Index sinking 0.9% and the SPDR Health Care Select Sector ETF (XLV)...
Fortress Biotech (FBIO) said Tuesday its UR-1 Therapeutics unit has dosed the first patient in a phase 1 trial of Dotinurad for the treatment of gout in...
...
| Address | 1111 Kane Concourse Bay Harbor Islands, Florida 33154 |
| Phone | +1.781.652.4500 |
| Number of Employees | 88 |
| Recent SEC Filing | 06/27/2022 8-K |
| Chairman, President & Chief Executive Officer | Lindsay Allan Rosenwald |
| Chief Financial Officer, Secretary & Treasurer | Robyn M. Hunter |
| Senior Vice President-Biologics Operations | George C. Avgerinos |
| Director & Vice Chairman-Strategic Development | Michael Sean Weiss |
| Price Open | $0.84 |
| Previous Close | $0.85 |
| 52 Week Range | $0.77 - 3.81 |
| Market Capitalization | $90.8 M |
| Shares Outstanding | 107.4 M |
| Sector | Health Technology |
| Industry | Pharmaceuticals: Major | Next Earnings Announcement | 08/15/2022 |
| Call Open Interest (1d)* |  |
| Put Open Interest (1d)* | |
| Call Volume (1d)* | |
| Put Volume (1d)* | |
| Put Call Open Interest Ratio (1d)* | |
| Put Call Volume Ratio (1d)* | |
| * Data delayed by up to 15 minutes |
| Price / Earnings | N/A |
| Earnings per Share | -$1.05 |
| Beta vs. S&P 500 | N/A |
| Revenue | $26.9 M |
| Net Profit Margin | -88.31% |
| Return on Equity | -70.33% |
| Buy | |
| Overweight | |
| Hold | |
| Underweight | |
| Sell | |
Consensus Recommendation | |
